STAT+: Rising wholesale drug prices really do matter to half of all commercially insured Americans



Although the pharmaceutical industry argues that wholesale prices do not accurately reflect prescription drug costs, a new study finds that rising wholesale prices have, in fact, led to higher out-of-pocket expenses for roughly half of insured patients.

The analysis examined 79 brand-name medicines from 2015 through 2017 and found that average wholesale prices — also referred to as list prices — increased by 16.7%. At the same time, there was a 5.4% rise in so-called net prices, which are paid by insurers and pharmacy benefit managers after drug makers offer rebates for more favorable insurance coverage.

Continue to STAT+ to read the full story…

Source link

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy